Trial Details
TERMINATEDBasic Information
| Clinical ID | c1145 |
|---|---|
| Identifier | NCT03139032 |
| Trial Title | Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Skin Extra-intestinal Manifestations |
| Interventions | DRUG: APD334 |
Participant Information
| Sponsor | Arena Pharmaceuticals |
|---|---|
| City | Leuven |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-07-17 |
|---|---|
| Primary Completion Date | 2017-12-06 |
| Completion Date | 2017-12-06 |